b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1261265/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1261265/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Infectious Diseases" /><meta name="citation_title" content="Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach" /><meta name="citation_authors" content="Michela Flego, Paola Di Bonito, Alessandro Ascione, Silvia Zamboni, Alessandra Carattoli, Felicia Grasso, Antonio Cassone, Maurizio Cianfriglia" /><meta name="citation_date" content="2005" /><meta name="citation_volume" content="5" /><meta name="citation_doi" content="10.1186/1471-2334-5-73" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1261265/?report=abstract" /><meta name="citation_pmid" content="16171519" /><meta name="DC.Title" content="Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Michela Flego" /><meta name="DC.Contributor" content="Paola Di Bonito" /><meta name="DC.Contributor" content="Alessandro Ascione" /><meta name="DC.Contributor" content="Silvia Zamboni" /><meta name="DC.Contributor" content="Alessandra Carattoli" /><meta name="DC.Contributor" content="Felicia Grasso" /><meta name="DC.Contributor" content="Antonio Cassone" /><meta name="DC.Contributor" content="Maurizio Cianfriglia" /><meta name="DC.Date" content="2005" /><meta name="DC.Identifier" content="10.1186/1471-2334-5-73" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach" /><meta property="og:type" content="article" /><meta property="og:description" content="Severe acute respiratory syndrome (SARS)-CoV is a newly emerging virus that causes SARS with high mortality rate in infected people. Successful control of the global SARS epidemic will require rapid and sensitive diagnostic tests to monitor its spread, ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1261265/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1261265/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1261265/pdf/12879_2005_Article_221.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1AB4E4E99A0DA10000000005840583.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC1261265</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">BMC Infectious Diseases</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Infect Dis</span>. 2005; 5: 73. </span></div><div><span class="fm-vol-iss-date">Published online 2005 Sep 19. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1471-2334-5-73" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1471-2334-5-73</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1261265</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/16171519">16171519</a></div></div></div></div><h1 class="content-title">Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Flego%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519" class="affpopup" co-rid="_co_idm140632896944112" co-class="co-affbox">Michela Flego</a>,<sup>1</sup> <a href="/pubmed/?term=Di%20Bonito%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519" class="affpopup" co-rid="_co_idm140632896941744" co-class="co-affbox">Paola Di Bonito</a>,<sup>2</sup> <a href="/pubmed/?term=Ascione%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519" class="affpopup" co-rid="_co_idm140632893053632" co-class="co-affbox">Alessandro Ascione</a>,<sup>1</sup> <a href="/pubmed/?term=Zamboni%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519" class="affpopup" co-rid="_co_idm140632893051264" co-class="co-affbox">Silvia Zamboni</a>,<sup>1</sup> <a href="/pubmed/?term=Carattoli%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519" class="affpopup" co-rid="_co_idm140632893048896" co-class="co-affbox">Alessandra Carattoli</a>,<sup>2</sup> <a href="/pubmed/?term=Grasso%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519" class="affpopup" co-rid="_co_idm140632896573200" co-class="co-affbox">Felicia Grasso</a>,<sup>2</sup> <a href="/pubmed/?term=Cassone%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519" class="affpopup" co-rid="_co_idm140632896570832" co-class="co-affbox">Antonio Cassone</a>,<sup>2</sup> and  <a href="/pubmed/?term=Cianfriglia%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519" class="affpopup" co-rid="_co_idm140632896568464" co-class="co-affbox">Maurizio Cianfriglia</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140632896944112"><h3 class="no_margin">Michela Flego</h3><p><sup>1</sup>Department of Drug Research and Evaluation, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </p><div>Find articles by <a href="/pubmed/?term=Flego%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519">Michela Flego</a></div></div><div id="_co_idm140632896941744"><h3 class="no_margin">Paola Di Bonito</h3><p><sup>2</sup>Department of Infectious Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </p><div>Find articles by <a href="/pubmed/?term=Di%20Bonito%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519">Paola Di Bonito</a></div></div><div id="_co_idm140632893053632"><h3 class="no_margin">Alessandro Ascione</h3><p><sup>1</sup>Department of Drug Research and Evaluation, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </p><div>Find articles by <a href="/pubmed/?term=Ascione%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519">Alessandro Ascione</a></div></div><div id="_co_idm140632893051264"><h3 class="no_margin">Silvia Zamboni</h3><p><sup>1</sup>Department of Drug Research and Evaluation, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </p><div>Find articles by <a href="/pubmed/?term=Zamboni%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519">Silvia Zamboni</a></div></div><div id="_co_idm140632893048896"><h3 class="no_margin">Alessandra Carattoli</h3><p><sup>2</sup>Department of Infectious Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </p><div>Find articles by <a href="/pubmed/?term=Carattoli%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519">Alessandra Carattoli</a></div></div><div id="_co_idm140632896573200"><h3 class="no_margin">Felicia Grasso</h3><p><sup>2</sup>Department of Infectious Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </p><div>Find articles by <a href="/pubmed/?term=Grasso%20F%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519">Felicia Grasso</a></div></div><div id="_co_idm140632896570832"><h3 class="no_margin">Antonio Cassone</h3><p><sup>2</sup>Department of Infectious Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </p><div>Find articles by <a href="/pubmed/?term=Cassone%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519">Antonio Cassone</a></div></div><div id="_co_idm140632896568464"><h3 class="no_margin">Maurizio Cianfriglia</h3><p><sup>1</sup>Department of Drug Research and Evaluation, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </p><div>Find articles by <a href="/pubmed/?term=Cianfriglia%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16171519">Maurizio Cianfriglia</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140632906026000_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140632906026000_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140632906026000_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140632906026000_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1"><sup>1</sup>Department of Drug Research and Evaluation, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </div><div class="fm-affl" lang="en" id="Aff2"><sup>2</sup>Department of Infectious Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanit&#x000e0;, Rome, Italy </div><div><span class="fm-affl">Michela Flego, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ssi@ogelf" class="oemail">ti.ssi@ogelf</a></span>.</div><div><a href="#idm140632906026000aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140632906026000_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2005 Apr 18; Accepted 2005 Sep 19.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140632906026000_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Flego et al; licensee BioMed Central Ltd. 2005</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1261265/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">Severe acute respiratory syndrome (SARS)-CoV is a newly emerging virus that causes SARS with high mortality rate in infected people. Successful control of the global SARS epidemic will require rapid and sensitive diagnostic tests to monitor its spread, as well as, the development of vaccines and new antiviral compounds including neutralizing antibodies that effectively prevent or treat this disease.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">The human synthetic single-chain fragment variable (scFv) ETH-2 phage antibody library was used for the isolation of scFvs against the nucleocapsid (N) protein of SARS-CoV using a bio panning-based strategy. The selected scFvs were characterized under genetics-molecular aspects and for SARS-CoV N protein detection in ELISA, western blotting and immunocytochemistry.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">Human scFv antibodies to N protein of SARS-CoV can be easily isolated by selecting the ETH-2 phage library on immunotubes coated with antigen. These <em>in vitro</em> selected human scFvs specifically recognize in ELISA and western blotting studies distinct epitopes in N protein domains and detect in immunohistochemistry investigations SARS-CoV particles in infected Vero cells.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">The human scFv antibodies isolated and described in this study represent useful reagents for rapid detection of N SARS-CoV protein and SARS virus particles in infected target cells.</p></div><div id="__sec5" class="sec sec-last"><h3 id="__sec5title">Electronic supplementary material</h3><p id="__p5" class="p p-first-last">The online version of this article (doi:10.1186/1471-2334-5-73) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Severe Acute Respiratory Syndrome, Severe Acute Respiratory Syndrome, scFv Antibody, Severe Acute Respiratory Syndrome Patient, Phage Antibody</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p6" class="p p-first">The widespread diffusion and mortality of severe acute respiratory syndrome (SARS), caused by a new <em>Coronavirus</em> (SARS-CoV) has threatened the entire world [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199598">1</a>] and has urged the scientific community to develop molecular and serological tests which can assist for rapid detection of SARS cases and implementation of control measures [<a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056415">2</a>]. Effective prophylaxis and antiviral therapies are urgently needed in the event of re-emergence of the highly contagious and often fatal SARS infection.</p><p id="__p7" class="p p-last">Like other known <em>Coronaviruses</em>, SARS-CoV is an enveloped virus containing four structural proteins, namely the membrane (M), envelope (E), spike (S) and the nucleocapsid (N) proteins [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199601">1</a>]. The N protein is a 423 amino acid, predicted phospho-protein of 46 kDa, which shares little homology with other members of the <em>Coronavirus</em> genus [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471858">3</a>, <a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471860">4</a>]. Several studies have found that N protein is highly immunogenic, thus antibody response in patients with SARS is directed most frequently and predominantly to the nucleocapsid. It has also been found that anti N antibodies are detected early and with high specificity during infection [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471861">5</a>]. Therefore, the generation of N-specific reagents, in particular monoclonal antibodies (mAbs) could be of assistance in studies of viral replication and antiviral activity, as well as in the diagnosis of SARS-CoV infection at various disease stages. It has also been found that SARS patients show clinical improvement if they are treated with serum from previously infected patients suggesting that passive immunotherapy could be developed for the treatment of this infectious disease [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199597">6</a>]. However, the traditional approach to generate mAbs to SARS-CoV has presented difficulties for several reasons including safety concerns in handling SARS particles [<a href="#CR7" rid="CR7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471857">7</a>]. To overcome these limitations, we applied a very effective and safe in <em>in vitro</em> procedure based on human scFvs selection from the large synthetic ETH-2 phage antibody library [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056419">8</a>]. Here, we report the identification, production, and epitope characterization of human scFv antibodies specifically recognizing distinct N protein domains. These recombinant mAbs were found to bind selectively and with good affinity to distinct N protein epitopes, and were suitable to specifically identify SARS particles in Vero infected cells.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">SARS-CoV antigens</h3><p id="__p8" class="p p-first-last">Nucleocapsid (N) protein of SARS-CoV (residues: 1&#x02013;422) and its fragments N1 (residues: 1&#x02013;117), N2 (residues: 110&#x02013;340) and N3 (residues: 333&#x02013;422) expressed in <em>E. coli</em> by DNA recombinant technology as reported by Carattoli, Di Bonito et al [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199602">9</a>]. These polypeptides have proved to react with specific sera of SARS-CoV infected patients.</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">ETH-2 antibody phage library</h3><p id="__p9" class="p p-first-last">The synthetic human recombinant antibodies library (ETH-2) consists of a large array (more than 10<sup>9</sup> antibody combination) of scFv polypeptides displayed on the surface of M13 phage. It was built by random mutagenesis of the CDR3 of only three antibody germline gene segments (DP47 for the heavy chain, DPK22 and DPL16 for the light chain). Diversity of the heavy chain was created by randomizing four to six positions replacing the pre-existing positions 95 to 98 of the CDR3. The diversity of the light chain was created by randomizing six positions (91 to 96) in the CDR3 [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056422">8</a>].</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">Isolation of phage antibodies from ETH-2 library</h3><p id="__p10" class="p p-first-last">An aliquot of the ETH-2 library, containing 10<sup>13</sup> cfu phage, was used to isolate specific human antibodies in scFv format to SARS-CoV N protein. Immunotubes (Nunc Maxisorp; Denmark) were coated overnight (ON) at room temperature (RT) with 10 &#x003bc;g/ml of recombinant purified SARS-CoV N protein in PBS. After panning, phages were eluted with 1 ml of 100 mM triethylamine and the solution was immediately neutralized by adding 0.5 ml of 1 M Tris-HCl pH 7.4. Eluted phages were used to infect log phase TG1 <em>E. coli</em> bacteria and amplified for the next round of selection. Briefly, 50 ml of 2 &#x000d7; YT with 100 &#x003bc;g/ml ampicillin (2 &#x000d7; YTA medium) and glucose 1% were inoculated with enough bacterial suspension to yield an OD<sub>600 nm</sub>&#x02245; 0.05&#x02013;0.1. The culture was grown up to OD<sub>600 nm</sub> 0.4&#x02013;0.5 and infected with M13 K07 helper phage in a ratio of around 20:1 phage/bacteria. The rescued phages were concentrated by precipitation with PEG 6000 and used for next round of panning (usually three to recover antigen-specific antibody phages from the ETH-2 library). For soluble scFv preparation, individual colonies were grown in 96 flat bottomed wells (Nunc) for 2 hours at 37&#x000b0;C in 180 &#x003bc;l 2 &#x000d7; YTA medium and glucose 0.1% in 96 well plates and inducted with 50 &#x003bc;l 2 &#x000d7; YTA medium and 6 mM IPTG. The following day the plates were spinned down at 1800 g for 10 minutes and the supernatants containing soluble scFvs were recovered and tested for specificity.</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">ELISA</h3><p id="__p11" class="p p-first-last">96 well ELISA-plates (Nunc Maxisorp) were coated ON at RT with 0.5 &#x003bc;g of antigen (N protein or its N1, N2, N3 fragments) in PBS. The following day a blocking solution, consisting of 2% non fat dry milk in PBS (MPBS), was added; plates were washed with PBS containing 0.05% Tween 20 (TPBS) and incubated for 2 hours at RT with 50 &#x003bc;l of supernatants containing soluble scFv antibody, anti-Flag M2 antibody (1.6 &#x003bc;g/ml Sigma-Aldrich; MO, USA) and anti-mouse HRP conjugated antibody (1.6 &#x003bc;g/ml Dako; Denmark). The reaction was developed using 3, 3<sup>1</sup>-5, 5<sup>1</sup>-tetramethylbenzidin BM blue, POD-substrate soluble (Roche Diagnostics; IN, USA) and stopped by adding 50 &#x003bc;l of 1 M sulfidric acid. The reaction was detected with an ELISA reader (Biorad; CA, USA), and the results were expressed as A (absorbance) = A(450 nm)-A(620 nm).</p></div><div id="Sec7" class="sec"><h3 id="Sec7title">Western blotting</h3><p id="__p12" class="p p-first-last">1 &#x003bc;g of SARS-CoV N, N1, N2 and N3 proteins were loaded onto 12% SDS-PAGE and transferred to a nitrocellulose membrane using standard procedures. The membrane was blocked in 4% MPBS ON at RT. Blotted proteins were incubated for 2 hours with supernatant containing soluble scFvs, washed with 0,05% TPBS and incubated again with 5 &#x003bc;g/ml anti-Flag M2 mouse antibody (Sigma-Aldrich) in 2% MPBS. After an additional incubation for 1 hour at RT in presence of 5 &#x003bc;g/ml of a goat anti-mouse antibody HRP-conjugated (Dako), the reaction was developed and visualized with a chemiluminescence detection kit (Pierce; IL, USA).</p></div><div id="Sec8" class="sec"><h3 id="Sec8title">Immunocytochemical determination of SARS-CoV particles</h3><p id="__p13" class="p p-first-last">BIOCHIP slides (Euroimmun, Luebeck, Germany) coated with SARS-CoV infected Vero cells were used for immunocytochemistry determination of virus particles by phage or scFv specific antibodies. Slides were treated for 10 minutes with peroxidase block solution (Dako En Vision System HRP), washed in TPBS buffer and incubated for 1 hour at RT with 10<sup>12</sup> phage antibody particles (resuspended in 25 &#x003bc;l of TPBS) or scFv containing supernatant (25 &#x003bc;l). As control, BIOCHIP slides were incubated with an irrelevant anti-glucose oxidase phage or scFv antibodies [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056426">10</a>]. After extensive washings with TPBS, the slides were incubated for 1 hour at RT with an anti-M13 secondary mouse antibody (5 &#x003bc;g/ml in 20 &#x003bc;l TPBS) (Amersham) or with an anti-FLAG secondary mouse antibody (5 &#x003bc;g/ml in 20 &#x003bc;l TPBS) (Sigma-Aldrich) for labelling phage and scFv reactive antibodies, respectively. After washings, the slides were treated for 30 minutes at RT with cromogen solutions (Dako) and inspected with a light microscope.</p></div><div id="Sec9" class="sec sec-last"><h3 id="Sec9title">DNA characterization and sequences</h3><p id="__p14" class="p p-first-last">Plasmid DNA from individual bacterial colonies of MA2.D5, MA2.D7 and MA2.E3 clones was digested with specific endonucleases and CDR3 regions sequenced with an automated DNA sequencer (M-Medical/Genenco, Pomezia, Italy) using fdseq1 (5\'-GAA TTT TCT GTA TGA GG-3\') and pelBback (5\'-AGC CGC TGG ATT GTT ATT AC-3\') primers.</p></div></div><div id="Sec10" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec10title">Results and discussion</h2><div id="Sec11" class="sec sec-first"><h3 id="Sec11title">Isolation of human scFv antibodies</h3><p id="__p15" class="p p-first-last">To isolate specific scFv antibodies, an aliquot of the human synthetic ETH-2 library containing approximately 1 &#x000d7; 10<sup>12</sup> cfu phages was introduced for panning into Maxisorp immunotubes coated with purified SARS-CoV N protein as antigen. Non-specifically absorbed phages were removed by washing. Bound phages were eluted, amplified and used for the next cycle of panning as described elsewhere [<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056421">8</a>, <a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056428">10</a>]. By using this protocol [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056416">10</a>], phage antibody populations specifically recognizing the N protein of SARS-CoV were isolated after only three rounds of selection. Plating on agar of TG1 phage antibody-infected cells, allowed growth of individual phagemid clones. Soluble scFvs derived from IPTG inducted colonies, were screened by ELISA and several of them proved to be specific for N protein (Figure <a href="/pmc/articles/PMC1261265/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure1</span></span><span>1</span></a>).\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC1261265/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140632903895056" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2005_Article_221_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2005_Article_221_Fig1_HTML.jpg" src="/pmc/articles/PMC1261265/bin/12879_2005_Article_221_Fig1_HTML.jpg" /></div><div id="largeobj_idm140632903895056" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1261265/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC1261265/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p16">\n<strong>N protein specific scFvs antibodies determined by ELISA.</strong> IPTG inducted bacterial supernatants of individual colonies from the third round of the ETH-2 library selection on N protein were tested in 96-well microtiter plates coated with antigen or glucose oxidase (negative control). ELISA readings higher than three fold above negative controls were scored as positive reactions. ELISA values of the scFv clones against N protein (panel A) and glucose oxidase (panel B) are shown.</p></div></div></div></div><div id="Sec12" class="sec"><h3 id="Sec12title">Epitope recognition</h3><p id="__p17" class="p p-first-last">N-positive scFv clones were analysed by ELISA for reactivity with N1, N2 and N3 protein fragments (Figure <a href="/pmc/articles/PMC1261265/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2).</span></span><span>2</span></a>). Three distinct classes of scFv antibodies recognizing either the intact N protein only or also N2 or N3 fragments were identified. ScFv antibodies recognizing N protein only but none of its fragments (for instance the MA2D5 scFv) were likely directed against epitopes encompassing two adjacent protein fragments or conformational epitopes expressed only on the integral protein. The absence of scFv antibodies reacting with the N1 fragment somewhat matches the lower antigenicity of this polypeptide, as compared to immunodominant N2 and N3 fragments, [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199603">9</a>], despite the reported reactivity of several linear synthetic epitopes of the N1 region with SARS sera [<a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471862">11</a>]. However, a relatively low number of scFv clones were here tested for a sound conclusion on this aspect.\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC1261265/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140632906256160" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2005_Article_221_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2005_Article_221_Fig2_HTML.jpg" src="/pmc/articles/PMC1261265/bin/12879_2005_Article_221_Fig2_HTML.jpg" /></div><div id="largeobj_idm140632906256160" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1261265/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC1261265/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p18">\n<strong>N protein domain recognition by specific scFv antibodies.</strong> The scFvs MA2.E3, MA2.D5 and MA2.D7 antibody clones showing distinct N protein recognition patterns in an ELISA (A, A\', A") were also analyzed for different epitope recognition by western blot. While all scFv antibodies react with a 46&#x02013;48 kDa band corresponding to the MW of the N protein (B, B\', B"), the scFvs MA2.E3 and MA2.D7 also react with a 28&#x02013;30 KDa and 12&#x02013;14 KDa band (B, B") corresponding to the MW of N2 and N3 protein fragments, respectively.</p></div></div></div></div><div id="Sec13" class="sec sec-last"><h3 id="Sec13title">SARS-CoV particles identification</h3><p id="__p19" class="p p-first">Three of the most reactive scFv antibody clones named MA2.D5, MA2.D7 and MA2.E3 each one representing the different classes of epitope recognition in the N protein domains were further assessed to verify their biochemical patterns, reactivity with SARS-CoV infected cells, and DNA sequences of their encoding genes.</p><p id="__p20">Western blotting analysis (Figure <a href="/pmc/articles/PMC1261265/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2)</span></span><span>2</span></a>) shows that all three antibodies react with a 46 kDa band corresponding to the predicted molecular mass of the intact N protein [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471864">3</a>]. As expected by previous ELISA indications, the scFvs MA2.E3 and MA2.D7 recognize also a 28&#x02013;30 kDa and 12&#x02013;14 kDa bands respectively, corresponding to the predicted molecular mass of N protein fragments N2 and N3 [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199596">9</a>].</p><p id="__p21" class="p p-last">The molecular analysis of the phage antibodies MA2.D5, MA2.D7 and MA2.E3 shows scFv antibodies with a molecular weight of about 27 kDa and the integrity of the genes encoding for the cognate scFvs displayed on M13 phage (data not show). VH and VL gene sequences, shows that each single scFv antibody clone possess a unique DNA sequence encoding for the CDR3 region (Figure <a href="/pmc/articles/PMC1261265/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3);</span></span><span>3</span></a>); this uniqueness is consistent with the distinct epitope recognition patterns of the three scFvs noted above. Immunocytochemical investigations show that MA2.D5 antibody specifically recognizes SARS-CoV particles in infected Vero cells (Figure <a href="/pmc/articles/PMC1261265/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure4).</span></span><span>4</span></a>). The other two antibodies MA2.D7 and MA2.E3, though genuinely reacting with N protein and its N2 and N3 fragments in ELISA and western blotting (see above) did not prove to be useful for SARS-CoV determination in infected cells.\n\n</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC1261265/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140632903753760" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2005_Article_221_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2005_Article_221_Fig3_HTML.jpg" src="/pmc/articles/PMC1261265/bin/12879_2005_Article_221_Fig3_HTML.jpg" /></div><div id="largeobj_idm140632903753760" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1261265/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC1261265/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p22">\n<strong>Molecular genetics characteristics of the scFv antibodies.</strong> The nucleotide composition, and the corresponding amino acid sequences and residue position in the CDR3 region of the selected scFv antibodies MA2.D5, MA2.D7 and MA2.E5 are reported. A schematic representation of the scFv antibodies displayed on M13 phage as pIII fusion proteins is depicted.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC1261265/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140632894678192" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2005_Article_221_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12879_2005_Article_221_Fig4_HTML.jpg" src="/pmc/articles/PMC1261265/bin/12879_2005_Article_221_Fig4_HTML.jpg" /></div><div id="largeobj_idm140632894678192" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1261265/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC1261265/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p23">\n<strong>SARS-CoV detection by MA2.D5 scFv antibody.</strong> The immunocytochemical detection of SARS-CoV particles in infected monkey Vero cells by the MA2.D5 antibody is shown in A (soluble scFv protein) and B (phage displaying scFv antibody). In C and D the reactivity of Vero cells with an irrelevant scFv and phage antibody are shown.</p></div></div></div></div></div><div id="Sec14" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec14title">Conclusion</h2><p id="__p24" class="p p-first">The usefulness of the library as a tool for generating monoclonal antibodies against viral pathogens [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056418">12</a>&#x02013;<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056408">14</a>] including SARS-CoV [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471863">15</a>, <a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199600">16</a>] has been tested and showing that phage antibodies may recognize viral proteins used as antigens. In particular, a rodent library has proved to be very effective for the isolation of murine scFvs exhibiting high specificity against SARS-CoV E protein, which is recognized as a 31 kDa protein in western blot studies [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471859">15</a>]. Interestingly, one of these clones (A17) isolated by selecting the rodent library against the 31 kDa E protein cross-reacts in ELISA with a well-defined fragment of the 46&#x02013;48 kDa N protein. Recently, human mAbs were identified by biopanning of a synthetic library on SARS-CoV lysate; the isolated scFvs expressed on phages have proved to recognize N protein only in ELISA while no evidences for N protein recognition in western blot studies or in SARS infected cells were shown [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199599">16</a>]. The efficient display of recombinant antibodies on filamentous phage has been also assessed by our findings showing that soluble human scFvs selected from the ETH-2 library may yield agents capable of specifically recognizing SARS-CoV particles in infected Vero cells as well as the intact 46&#x02013;48 kDa SARS-CoV N protein and its N2 (28&#x02013;30 kDa) and N3 (12&#x02013;14 kDa) fragments in western blot and ELISA investigations (Figure <a href="/pmc/articles/PMC1261265/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2</span></span><span>2</span></a> and <a href="/pmc/articles/PMC1261265/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -1.5em;">and4).</span></span><span>4</span></a>). To our knowledge, the human scFvs directed against N protein, by us isolated and characterized, are the first antibodies so far described which are able to detect SARS-CoV N protein in different routinary laboratory techniques such as ELISA, Western blot and immunocytochemistry. Hence, these human mAbs represent excellent candidates for future development of serological diagnosis of SARS-CoV infections since high functionality (all clones express soluble antibodies in bacteria), specificity (all clones recognize the 46&#x02013;48 kDa N protein) and quality (all clones give good signals in ELISA, in western blot as well and stain SARS-CoV infected cells).</p><p id="__p25">Furthermore, the genes encoding for the selected MA2.D5, MA2.D7 and MA2.E3 antibodies have been isolated and sequenced, thus facilitating various molecular approaches including site direct mutagenesis to maturate binding affinity and construct whole recombinant immunoglobulins for SARS-CoV studies and applications. To this latter regard, another immediate use of human scFv directed to N protein is through intracellular expression as a novel strategy of gene therapy aimed at knockout the replicative cycle of SARS-CoV in infected cells. It is thought that intracellular expression of scFv antibodies may be superior over alternative methods for gene inactivation such as anti-sense RNA and dominant negative mutants because of its high specificity [<a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056410">17</a>, <a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056406">18</a>].</p><p id="__p26" class="p p-last">Nevertheless, phage display approach make feasible several strategies for the isolation of neutralizing human mAbs to provide an immediate treatment for emergency prophylaxis of SARS-CoV [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056412">19</a>] while vaccines and new drugs are underway. For example, immune library may be constructed and screened on SARS-CoV proteins, using B-cells from convalescent SARS patients as a genetic source of specific VH and VL. In alternative, synthetic peptides mimicking immunodominant epitopes in S or M SARS-CoV proteins [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844056425">20</a>] may be used as a substrate antigens for the identification of specific scFvs from synthetic human phage antibody library.</p></div><div id="idm140632899609568" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140632899609568title">Acknowledgements</h2><div class="sec"><p id="__p48">We are grateful to Mrs. S. Tocchio for editorial assistance. This work was supported by a grant from Ministero della Salute, Italy, under contract for "Progetto Speciale Lotta alla SARS". MF is supported by an AIDS grant from the Italian Ministry of Health.</p></div></div><div id="idm140632902141072" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140632902141072title">List of abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>SARS</td><td>Severe Acute Respiratory Syndrome</td></tr><tr><td>CoV</td><td>\n<em>Coronavirus</em>\n</td></tr><tr><td>N</td><td>Nucleocapsid</td></tr><tr><td>scFv</td><td>single chain fragment variable</td></tr><tr><td>ETH-2</td><td>synthetic scFv antibody phage library</td></tr><tr><td>CDR</td><td>complementarity determining regions</td></tr><tr><td>mAbs</td><td>monoclonal antibodies.</td></tr></tbody></table></div></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec15" class="sec sec-first"><h3 id="Sec15title">Authors&#x02019; original submitted files for images</h3><p id="__p27" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC1261265/bin/12879_2005_221_MOESM1_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(48K, ppt)</sup></span>\n<span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC1261265/bin/12879_2005_221_MOESM2_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(302K, ppt)</sup></span>\n<span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC1261265/bin/12879_2005_221_MOESM3_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(59K, ppt)</sup></span>\n<span class="sup-box" id="MOESM4"><a href="/pmc/articles/PMC1261265/bin/12879_2005_221_MOESM4_ESM.ppt" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 4</a><sup>(8.2M, ppt)</sup></span>\n</p></div></div><div id="idm140632902852464" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140632902852464title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140632902852336"><p id="__p39" class="p p-first"><strong>Competing interests</strong></p><p id="__p40" class="p p-last">The author(s) declare that they have not competing interest.</p></p><p class="fn sec" id="idm140632899614496"><p id="__p41" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p42" class="p">MF carried out phage antibodies and scFvs selection from all different N-antigens, participated in the genetic molecular, biochemical and immunohistochemical characterization of scFvs specific for distinct epitopes of N protein.</p><p id="__p43" class="p">PDB and FG carried out isolation, expression, production and purification of nucleocapsid protein from SARS-CoV.</p><p id="__p44" class="p">AA participated in phage antibodies selection and carried out immunoassay and biochemical characterization of scFvs against N protein and its polypeptide fragments.</p><p id="__p45" class="p">ACr firstly, ideated and developed a genetic molecular model to isolate, identify and express SARS-CoV N protein and its fragments.</p><p id="__p46" class="p">AC promotes the genetic molecular study of SARS-CoV N protein, participated in the design of the study, supervisioned the experiments and critically revised the manuscript. MC conceived of the study, promotes the approach with phage library to select specific scFv human antibodies against SARS-CoV protein. Furthermore, MC participated in the design and coordination of the research and drafting the manuscript.</p><p id="__p47" class="p p-last">All authors have read and approved the final version of the manuscript.</p></p></div></div><div id="idm140632906026000aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140632906026000aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Michela Flego, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ssi@ogelf" class="oemail">ti.ssi@ogelf</a></span>.</p><p><span class="fm-affl">Paola Di Bonito, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ssi@otinobid" class="oemail">ti.ssi@otinobid</a></span>.</p><p><span class="fm-affl">Alessandro Ascione, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.oohaY@4791onaif" class="oemail">ti.oohaY@4791onaif</a></span>.</p><p><span class="fm-affl">Silvia Zamboni, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ssi@inobmaz" class="oemail">ti.ssi@inobmaz</a></span>.</p><p><span class="fm-affl">Alessandra Carattoli, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ssi@aracela" class="oemail">ti.ssi@aracela</a></span>.</p><p><span class="fm-affl">Felicia Grasso, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ssi@ossarg" class="oemail">ti.ssi@ossarg</a></span>.</p><p><span class="fm-affl">Antonio Cassone, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ssi@enossac" class="oemail">ti.ssi@enossac</a></span>.</p><p><span class="fm-affl">Maurizio Cianfriglia, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ti.ssi@irfnaic" class="oemail">ti.ssi@irfnaic</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="mixed-citation">Peiris JS, Guan Y, Yuen KY: Severe acute respiratory syndrome. Nat Med. 2004, 88-97. 10.1038/nm1143. Suppl 12 <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7096017/">PMC free article</a>]</span> [<a href="/pubmed/15577937" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Bermingham A, Heinen P, Iturriza-Gomara M, Gray J, Appleton H, Zambon MC. Laboratory diagnosis of SARS. <span><span class="ref-journal">Philos Trans R Soc Lond B Biol Sci. </span>2004;<span class="ref-vol">359</span>:1083\xe2\x80\x931089. doi: 10.1098/rstb.2004.1493.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1693399/">PMC free article</a>]</span> [<a href="/pubmed/15306394" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1098%2Frstb.2004.1493" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Philos+Trans+R+Soc+Lond+B+Biol+Sci&amp;title=Laboratory+diagnosis+of+SARS&amp;author=A+Bermingham&amp;author=P+Heinen&amp;author=M+Iturriza-Gomara&amp;author=J+Gray&amp;author=H+Appleton&amp;volume=359&amp;publication_year=2004&amp;pages=1083-1089&amp;pmid=15306394&amp;doi=10.1098/rstb.2004.1493&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Timani KA, Ye L, Ye L, Zhu Y, Wu Z, Gong Z. Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS. <span><span class="ref-journal">J Clin Virol. </span>2004;<span class="ref-vol">30</span>:309\xe2\x80\x93312. doi: 10.1016/j.jcv.2004.01.001.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7130062/">PMC free article</a>]</span> [<a href="/pubmed/15163419" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jcv.2004.01.001" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Virol&amp;title=Cloning,+sequencing,+expression,+and+purification+of+SARS-associated+coronavirus+nucleocapsid+protein+for+serodiagnosis+of+SARS&amp;author=KA+Timani&amp;author=L+Ye&amp;author=L+Ye&amp;author=Y+Zhu&amp;author=Z+Wu&amp;volume=30&amp;publication_year=2004&amp;pages=309-312&amp;pmid=15163419&amp;doi=10.1016/j.jcv.2004.01.001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Surjit M, Liu B, Kumar P, Chow VT, Lal SK. The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2004;<span class="ref-vol">317</span>:1030\xe2\x80\x931036. doi: 10.1016/j.bbrc.2004.03.154.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7111157/">PMC free article</a>]</span> [<a href="/pubmed/15094372" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.bbrc.2004.03.154" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=The+nucleocapsid+protein+of+the+SARS+coronavirus+is+capable+of+self-association+through+a+C-terminal+209+amino+acid+interaction+domain&amp;author=M+Surjit&amp;author=B+Liu&amp;author=P+Kumar&amp;author=VT+Chow&amp;author=SK+Lal&amp;volume=317&amp;publication_year=2004&amp;pages=1030-1036&amp;pmid=15094372&amp;doi=10.1016/j.bbrc.2004.03.154&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Leung DT, Tam FC, Ma CH, Chan PK, Cheung JL, Niu H, Tam JS, Lim PL. Antibody response of patients with severe acute respiratory syndrome (SARS) targets the viral nucleocapsid. <span><span class="ref-journal">J Infect Dis. </span>2004;<span class="ref-vol">190</span>:379\xe2\x80\x93386. doi: 10.1086/422040.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7110057/">PMC free article</a>]</span> [<a href="/pubmed/15216476" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F422040" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Antibody+response+of+patients+with+severe+acute+respiratory+syndrome+(SARS)+targets+the+viral+nucleocapsid&amp;author=DT+Leung&amp;author=FC+Tam&amp;author=CH+Ma&amp;author=PK+Chan&amp;author=JL+Cheung&amp;volume=190&amp;publication_year=2004&amp;pages=379-386&amp;pmid=15216476&amp;doi=10.1086/422040&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Burnouf T, Radosevich M. Treatment of severe acute respiratory syndrome with convalescent plasma. <span><span class="ref-journal">Hong Kong Med J. </span>2003;<span class="ref-vol">4</span>:309\xe2\x80\x93310.</span> [<a href="/pubmed/12904626" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hong+Kong+Med+J&amp;title=Treatment+of+severe+acute+respiratory+syndrome+with+convalescent+plasma&amp;author=T+Burnouf&amp;author=M+Radosevich&amp;volume=4&amp;publication_year=2003&amp;pages=309-310&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Xiong S, Wang YF, Zhang MY, Liu XJ, Zhang CH, Liu SS, Qian CW, Li JX, Lu JH, Wan ZY, Zheng HY, Yan XG, Meng MJ, Fan JL. Immunogenicity of SARS inactivated vaccine in BALB/c mice. <span><span class="ref-journal">Immunol Lett. </span>2004;<span class="ref-vol">95</span>:139\xe2\x80\x93143. doi: 10.1016/j.imlet.2004.06.014.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112924/">PMC free article</a>]</span> [<a href="/pubmed/15388253" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.imlet.2004.06.014" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Lett&amp;title=Immunogenicity+of+SARS+inactivated+vaccine+in+BALB/c+mice&amp;author=S+Xiong&amp;author=YF+Wang&amp;author=MY+Zhang&amp;author=XJ+Liu&amp;author=CH+Zhang&amp;volume=95&amp;publication_year=2004&amp;pages=139-143&amp;pmid=15388253&amp;doi=10.1016/j.imlet.2004.06.014&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Viti F, Nilsson F, Demartis S, Huber A, Neri D. Design and use of phage display libraries for the selection of antibodies and enzymes. <span><span class="ref-journal">Methods Enzymol. </span>2000;<span class="ref-vol">326</span>:480\xe2\x80\x93505. doi: 10.1016/S0076-6879(00)26071-0.</span> [<a href="/pubmed/11036659" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0076-6879(00)26071-0" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Methods+Enzymol&amp;title=Design+and+use+of+phage+display+libraries+for+the+selection+of+antibodies+and+enzymes&amp;author=F+Viti&amp;author=F+Nilsson&amp;author=S+Demartis&amp;author=A+Huber&amp;author=D+Neri&amp;volume=326&amp;publication_year=2000&amp;pages=480-505&amp;pmid=11036659&amp;doi=10.1016/S0076-6879(00)26071-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Carattoli A, Di Bonito P, Grasso F, Giorgi C, Blasi F, Niedrig M, Cassone A.  <span class="ref-journal">J Med Virol.</span> 2005. Recombinant protein-based ELISA and immuno-cytochemical assay in diagnosis of Sars. [<a href="/pubmed/15834868" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=J+Med+Virol&amp;author=A+Carattoli&amp;author=P+Di+Bonito&amp;author=F+Grasso&amp;author=C+Giorgi&amp;author=F+Blasi&amp;publication_year=2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Ascione A, Flego M, Zamboni S, De Cinti E, Dupuis ML, Cianfriglia M. Isolation and characterization of the human monoclonal antibodies C10 in single-chain fragment variable (scFv) format to glucose oxidase from Aspergillus niger. <span><span class="ref-journal">Hybrid Hybridomics. </span>2004;<span class="ref-vol">23</span>:380\xe2\x80\x93384. doi: 10.1089/hyb.2004.23.380.</span> [<a href="/pubmed/15684666" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1089%2Fhyb.2004.23.380" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hybrid+Hybridomics&amp;title=Isolation+and+characterization+of+the+human+monoclonal+antibodies+C10+in+single-chain+fragment+variable+(scFv)+format+to+glucose+oxidase+from+Aspergillus+niger&amp;author=A+Ascione&amp;author=M+Flego&amp;author=S+Zamboni&amp;author=E+De+Cinti&amp;author=ML+Dupuis&amp;volume=23&amp;publication_year=2004&amp;pages=380-384&amp;pmid=15684666&amp;doi=10.1089/hyb.2004.23.380&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Wang J, Wen J, Li J, Yin J, Zhu Q, Wang H, Yang Y, Qin E, You B, Li W, Li X, Huang S, Yang R, Zhang X, Yang L, Zhang T, Yin Y, Cui X, Tang X, Wang L, He B, Ma L, Lei T, Zeng C, Fang J, Yu J, Wang J, Yang H, West MB, Bhatnagar A, Lu Y, Xu N, Liu S. Assessment of Immunoreactive Synthetic Peptides from the Structural Proteins of Severe Acute Respiratory Syndrome Coronavirus. <span><span class="ref-journal">Clin Chem. </span>2003;<span class="ref-vol">49</span>:1989\xe2\x80\x931996. doi: 10.1373/clinchem.2003.023184.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7108193/">PMC free article</a>]</span> [<a href="/pubmed/14633869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1373%2Fclinchem.2003.023184" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Chem&amp;title=Assessment+of+Immunoreactive+Synthetic+Peptides+from+the+Structural+Proteins+of+Severe+Acute+Respiratory+Syndrome+Coronavirus&amp;author=J+Wang&amp;author=J+Wen&amp;author=J+Li&amp;author=J+Yin&amp;author=Q+Zhu&amp;volume=49&amp;publication_year=2003&amp;pages=1989-1996&amp;pmid=14633869&amp;doi=10.1373/clinchem.2003.023184&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Veiga E, De Lorenzo, Fernandez LA. Neutralization of enteric coronaviruses with Escherichia coli cells expressing single-chain Fv-autotransporter fusions. <span><span class="ref-journal">J Virol. </span>2003;<span class="ref-vol">77</span>:13396\xe2\x80\x9313398. doi: 10.1128/JVI.77.24.13396-13398.2003.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC296075/">PMC free article</a>]</span> [<a href="/pubmed/14645594" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.77.24.13396-13398.2003" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Neutralization+of+enteric+coronaviruses+with+Escherichia+coli+cells+expressing+single-chain+Fv-autotransporter+fusions&amp;author=E+Veiga&amp;author=Lorenzo+De&amp;author=LA+Fernandez&amp;volume=77&amp;publication_year=2003&amp;pages=13396-13398&amp;pmid=14645594&amp;doi=10.1128/JVI.77.24.13396-13398.2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Hayhurst A, Happe S, Mabry R, Koch Z, Iverson BL, Georgiou G. Isolation and expression of recombinant antibody fragment to the biological warfare pathogen Brucella melitensis. <span><span class="ref-journal">J Immunol Methods. </span>2003;<span class="ref-vol">276</span>(1-2):185\xe2\x80\x93196. doi: 10.1016/S0022-1759(03)00100-5.</span> [<a href="/pubmed/12738372" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0022-1759(03)00100-5" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol+Methods&amp;title=Isolation+and+expression+of+recombinant+antibody+fragment+to+the+biological+warfare+pathogen+Brucella+melitensis&amp;author=A+Hayhurst&amp;author=S+Happe&amp;author=R+Mabry&amp;author=Z+Koch&amp;author=BL+Iverson&amp;volume=276&amp;issue=1-2&amp;publication_year=2003&amp;pages=185-196&amp;pmid=12738372&amp;doi=10.1016/S0022-1759(03)00100-5&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Sapats SI, Heine HG, Trinidad L, Gould GJ, Foord AJ, Doolan SG, Prowse S, Ignjatovic J. Generation of chiken single chain antibody variable fragments (scFv) that differentiate and neutralize infectious bursal disease virus (IBDV) <span><span class="ref-journal">Arch Virol. </span>2003;<span class="ref-vol">148</span>:497\xe2\x80\x93515. doi: 10.1007/s00705-002-0931-2.</span> [<a href="/pubmed/12607101" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs00705-002-0931-2" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Virol&amp;title=Generation+of+chiken+single+chain+antibody+variable+fragments+(scFv)+that+differentiate+and+neutralize+infectious+bursal+disease+virus+(IBDV)&amp;author=SI+Sapats&amp;author=HG+Heine&amp;author=L+Trinidad&amp;author=GJ+Gould&amp;author=AJ+Foord&amp;volume=148&amp;publication_year=2003&amp;pages=497-515&amp;pmid=12607101&amp;doi=10.1007/s00705-002-0931-2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Liu H, Ding YL, Han W, Liu MY, Tian RY, Yang SL, Gong Y. Recombinant scFv antibodies against E protein and N protein of severe acute respiratory syndrome virus. <span><span class="ref-journal">Acta Biochim Biophys Sin (Shanghai) </span>2004;<span class="ref-vol">36</span>:541\xe2\x80\x93547. doi: 10.1093/abbs/36.8.541.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7110246/">PMC free article</a>]</span> [<a href="/pubmed/15295646" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fabbs%2F36.8.541" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Acta+Biochim+Biophys+Sin+(Shanghai)&amp;title=Recombinant+scFv+antibodies+against+E+protein+and+N+protein+of+severe+acute+respiratory+syndrome+virus&amp;author=H+Liu&amp;author=YL+Ding&amp;author=W+Han&amp;author=MY+Liu&amp;author=RY+Tian&amp;volume=36&amp;publication_year=2004&amp;pages=541-547&amp;pmid=15295646&amp;doi=10.1093/abbs/36.8.541&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Liu ZX, Yi GH, Qi YP, Liu YL, Yan JP, Qian J, Du EQ, Ling WF. Identification of single-chain antibody fragments specific against SARS-associated coronavirus from phage-displayed antibody library. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2005;<span class="ref-vol">329</span>:437\xe2\x80\x93444. doi: 10.1016/j.bbrc.2005.02.003.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7092915/">PMC free article</a>]</span> [<a href="/pubmed/15737606" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.bbrc.2005.02.003" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Identification+of+single-chain+antibody+fragments+specific+against+SARS-associated+coronavirus+from+phage-displayed+antibody+library&amp;author=ZX+Liu&amp;author=GH+Yi&amp;author=YP+Qi&amp;author=YL+Liu&amp;author=JP+Yan&amp;volume=329&amp;publication_year=2005&amp;pages=437-444&amp;pmid=15737606&amp;doi=10.1016/j.bbrc.2005.02.003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Cattaneo A, Biocca S. The selection of intracellular antibodies. <span><span class="ref-journal">Trends Biotechnol. </span>1999;<span class="ref-vol">17</span>:115\xe2\x80\x93121. doi: 10.1016/S0167-7799(98)01268-2.</span> [<a href="/pubmed/10189716" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0167-7799(98)01268-2" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Trends+Biotechnol&amp;title=The+selection+of+intracellular+antibodies&amp;author=A+Cattaneo&amp;author=S+Biocca&amp;volume=17&amp;publication_year=1999&amp;pages=115-121&amp;pmid=10189716&amp;doi=10.1016/S0167-7799(98)01268-2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Jannot CB, Beerli RR, Mason S, Gullick WJ, Hynes NE. Intracellular expression of a single chain antibody directed to the EGFR leads to growth inhibition of tumour cells. <span><span class="ref-journal">Oncogene. </span>1996;<span class="ref-vol">13</span>:275\xe2\x80\x93282.</span> [<a href="/pubmed/8710366" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Intracellular+expression+of+a+single+chain+antibody+directed+to+the+EGFR+leads+to+growth+inhibition+of+tumour+cells&amp;author=CB+Jannot&amp;author=RR+Beerli&amp;author=S+Mason&amp;author=WJ+Gullick&amp;author=NE+Hynes&amp;volume=13&amp;publication_year=1996&amp;pages=275-282&amp;pmid=8710366&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Sui J, Li W, Roberts A, Matthews LJ, Murakami A, Vogel L, Wong SK, Subbarao K, Farzan M, Marasco WA. Evaluation of human monoclonal antibody 80R for immunoprophylaxis of severe acute respiratory syndrome by an animal study, epitope mapping, and analysis of spike variants. <span><span class="ref-journal">J Virol. </span>2005;<span class="ref-vol">79</span>:5900\xe2\x80\x936. doi: 10.1128/JVI.79.10.5900-5906.2005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1091676/">PMC free article</a>]</span> [<a href="/pubmed/15857975" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.79.10.5900-5906.2005" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Evaluation+of+human+monoclonal+antibody+80R+for+immunoprophylaxis+of+severe+acute+respiratory+syndrome+by+an+animal+study,+epitope+mapping,+and+analysis+of+spike+variants&amp;author=J+Sui&amp;author=W+Li&amp;author=A+Roberts&amp;author=LJ+Matthews&amp;author=A+Murakami&amp;volume=79&amp;publication_year=2005&amp;pages=5900-6&amp;pmid=15857975&amp;doi=10.1128/JVI.79.10.5900-5906.2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Zhong X, Yang H, Guo ZF, Sin WY, Chen W, Xu J, Fu L, Wu J, Mak CK, Cheng CS, Yang Y, Cao S, Wong TY, Lai ST, Xie Y, Guo Z. B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. <span><span class="ref-journal">J Virol. </span>2005;<span class="ref-vol">79</span>:3401\xe2\x80\x933048. doi: 10.1128/JVI.79.6.3401-3408.2005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1075701/">PMC free article</a>]</span> [<a href="/pubmed/15731234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.79.6.3401-3408.2005" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=B-cell+responses+in+patients+who+have+recovered+from+severe+acute+respiratory+syndrome+target+a+dominant+site+in+the+S2+domain+of+the+surface+spike+glycoprotein&amp;author=X+Zhong&amp;author=H+Yang&amp;author=ZF+Guo&amp;author=WY+Sin&amp;author=W+Chen&amp;volume=79&amp;publication_year=2005&amp;pages=3401-3048&amp;pmid=15731234&amp;doi=10.1128/JVI.79.6.3401-3408.2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div><div class="ref-list-sec sec" id="BSec1"><h2 id="BSec1title">Pre-publication history</h2><ul class="back-ref-list" style="list-style-type:decimal;"><li id="CR21"><span class="mixed-citation">The pre-publication history for this paper can be accessed here:<a href="http://www.biomedcentral.com/1471-2334/5/73/prepub" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=1261265&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=External%7CLink%7CURI" target="_blank">http://www.biomedcentral.com/1471-2334/5/73/prepub</a></span></li></ul></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1261265/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1261265/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1261265/pdf/12879_2005_Article_221.pdf">PDF (2.2M)</a></li> | <li><a href="#" data-citationid="PMC1261265" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1261265%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1261265%2F&amp;text=Generation%20of%20human%20antibody%20fragments%20recognizing%20distinct%20epitopes%20of%20the%20nucleocapsid%20(N)%20SARS-CoV%20protein%20using%20a%20phage%20display%20approach"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1261265%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="16171519" data-aiid="7090867" data-aid="1261265" data-iid="354737" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC1261265" data-md5="cea32837ca798eadaf79db445d695dcc"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:10:58-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1AB4E4E99A0DA10000000005840583&amp;ncbi_session=8A1AB4E4E99AAE11_1412SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1261265%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1261265/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1AB4E4E99AAE11_1412SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'